
Sucralose is the sweetening ingredient in SPLENDA® Sweetener Products.
Sucralose is one of the most rigorously tested food additives and has been the subject of more than 110 scientific studies to establish its safety.1-4
Based on independent evaluations of study results, the FDA and health authorities in other countries have concluded that sucralose is suitable for use by everyone.
Read Who Can Use Sucralose? below.
|
Conclusions that are based on the full body of sucralose safety studies include the following: |
|||||||||||||||||||||||||
|
|
Read about FDA approval of sucralose and view clinical studies.
Sucralose (SPLENDA® Brand Sweetener) is suitable for everyone, including:
Sucralose is not recognized by the body as a carbohydrate, is not metabolized for energy, and provides no calories.
Clinical trials among patients with diabetes and among normal controls have shown that sucralose has no effect on insulin levels, fasting or postprandial blood glucose levels, and long-term blood glucose control (hemoglobin A1c).4-6 A multicenter study demonstrated that daily sucralose consumption of triple the maximum projected daily intake for 3 months had no effect on glucose homeostasis in patients with type 2 diabetes.6
Sucralose can be used safely during pregnancy and by nursing mothers. Studies in animal models showed that sucralose is not actively transported across the placental barrier or from the mammary gland into breast milk.
While mothers typically have higher nutritional needs during pregnancy and nursing, sucralose may help women avoid excess calorie intake during these times. For some women, sucralose may be part of a strategy to reduce the risk of unnecessary weight gain.
The prevalence of overweight/obesity in children is reaching alarming proportions. According to the most recent data from the Centers for Disease Control and Prevention, 16% of US children ages 6-19 are overweight.7 Substituting sugar with SPLENDA® Sweetener Products is an excellent way to help children lower their sugar and calorie intake.